Amy Safadi, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    TG therapeutics
    Topic:
    Advisory Board - one time
    Date added:
    01/15/2025
    Date updated:
    03/10/2026
    Relationship end date:
    11/18/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    EMD Sorono
    Topic:
    Advisory Board - one time
    Date added:
    01/15/2025
    Date updated:
    03/10/2026
    Relationship end date:
    09/20/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Genentech
    Topic:
    Advisory Board - one time
    Date added:
    02/09/2025
    Date updated:
    03/10/2026
    Relationship end date:
    02/26/2025
Return to 2026 Neurology Grand Rounds: Beyond Relapses -- Rethinking Multiple Sclerosis in 2026 and Beyond